Page last updated: 2024-08-25

uk 68798 and Atrial Fibrillation

uk 68798 has been researched along with Atrial Fibrillation in 137 studies

Research

Studies (137)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	14 (10.22)	18.2507
2000's	80 (58.39)	29.6817
2010's	36 (26.28)	24.3611
2020's	7 (5.11)	2.80

Authors

Authors	Studies
Amin, AK; Billakanty, SR; Chopra, N; El-Zein, R; Fu, EY; Khan, ZA; LaBreck, ME; Luli, J; Roberts, C; Smith, A; Tyler, JD	1
Bonilla, IM; Carnes, CA; Cui, X; Einolf, HJ; Eisenmann, ED; Fromm, MF; Fu, Q; Garrison, DA; Gibson, AA; Hu, S; Huang, KM; Jay, CE; Jin, Y; König, J; Li, Y; Millar, A; Nepal, M; Pelis, RM; Radwański, PB; Smith, SA; Sparreboom, A; Sun, X; Sweet, DH; Talebi, Z; Tarasov, M; Uddin, ME	1
Knowles, D; Malloy, R; Ting, C	1
Baranowski, B; Bhargava, M; Callahan, TD; Cantillon, DJ; Chung, MK; Dresing, TJ; Hussein, AA; Kanj, M; Koene, RJ; Lindsay, BD; Martin, DO; Menon, V; Niebauer, MJ; Rickard, JW; Saliba, WI; Tarakji, KG; Tchou, PJ; Varma, N; Wazni, OM; Wilkoff, BL	1
Kantharia, BK; Mascarenhas, DAN; Mudumbi, PC	1
Cicirale, C; Gothard, D; Jackson, J	1
Batul, A; Bogun, F; Chugh, A; Chung, E; Crawford, T; Cunnane, R; Ghanbari, H; Ghannam, M; Jongnarangsin, K; Latchamsetty, R; Liang, J; Morady, F; Oral, H; Pelosi, F; Saeed, M; Shantha, G	1
Backx, PH; Gepstein, L; Izaddoustdar, F; Keller, G; Laksman, Z; Lee, J; Lin, E; Protze, S; Shafaattalab, S; Tibbits, GF; Wauchop, M; Yang, W	1
Baczkó, I; Benák, A; Hornyik, T; Husti, Z; Juhász, V; Nagy, N; Pap, R; Sághy, L; Varró, A; Virág, L	1
Buhl, R; Carstensen, H; Flethøj, M; Haugaard, MM; Hesselkilde, EZ; Jespersen, T; Kanters, JK; Kjær, L; Pehrson, S	1
Anzia, LE; Bassiouny, M; Bhargava, M; Chung, M; Desai, M; Garberich, R; Lever, H; Lindsay, BD; Moore, JC; Saliba, W; Sengupta, J; Tchou, P; Trager, L; Wazni, O; Wilkoff, BL	1
Al-Khatib, SM; Allen LaPointe, NM; Bahnson, TD; Campbell, KB; Daubert, JP; Jackson, KP; Picini, JP; Pokorney, SD; Sheng, S; Thomas, KL; Thomas, L; Yen, DC	1
AlMahameed, ST; Garner, HR; Kim, DM; Kinney, N; Larsen, TR; Poelzing, S; Varghese, RT	1
Hussain, S; Maraj, I; Naccarelli, GV; Wolbrette, DL	1
Ackerman, MJ; Asirvatham, SJ; DeSimone, CV; Kapa, S; Kella, D; Lee, HC; Naksuk, N; Noseworthy, PA; Padmanabhan, D; Sugrue, AM	1
Buhl, R; Carlson, J; Carstensen, H; Flethøj, M; Haugaard, MM; Hesselkilde, EZ; Jespersen, T; Pehrson, S; Platonov, PG	1
Steckman, D; Zhang, L	1
Atkins, D; Bommana, S; Carroll, H; Gopinathannair, R; Jeffrey, C; Lakkireddy, D; Natale, A; Newton, D; Nydegger, C; Sharma, SP; Turagam, M	1
Adelstein, E; Barrington, W; Bazaz, R; Brumberg, G; Gera, N; Jain, SK; Mendenhall, GS; Nemec, J; Pray, C; Saba, S; Schwartzman, D; Voigt, A; Wang, NC	1
Adhaduk, M; Arshad, A; Mittal, S; Musat, DL; Preminger, MW; Sichrovsky, T; Steinberg, JS	1
Bilchick, KC; DiMarco, JP; Malhotra, R	1
Da Costa, D; Kolasa, M; Koyama, G; McGregor, P; Shah, SA	1
Eggertson, L	1
Crist, LW; Dixon, DL	1
Dorsey, P; Hayes, M; Kaplan, R; Passman, R; Sauer, AJ; Shah, SJ; Xue, J	1
Fukuda, K; Hashimoto, N; Ishiwata, N; Kobayashi, T; Machida, T; Matsuura, J; Miyoshi, S; Nakaya, H; Ogawa, S; Ogino, Y; Tanimoto, K; Yamamoto, W; Yamanaka, Y; Yamashita, T	1
Akerman, S; Dixit, S; Epstein, AE; Frankel, DS; Khurshid, S; Man, JP; Marchlinski, FE; Supple, G	1
Agusala, K; Caprio, T; Kulkarni, C; Oesterle, A; Passman, R; Subacius, H	1
Goldberger, JJ; Ng, J; Raygor, VP	1
Abraham, JM; Bassiouny, M; Bhargava, M; Janiszewski, D; Lawrence, D; Lindsay, B; Militello, M; Nissen, SE; Poe, S; Saliba, WI; Tanaka-Esposito, C; Vekstein, C; Wilkoff, BL; Wolski, K	1
Adelstein, E; Alam, MB; Jain, SK; Khattak, F; Leef, G; Munir, MB; Patel, D; Qin, D; Rattan, R; Saba, S	1
Huang, HD; Steinhaus, DA; Waks, JW; Zimetbaum, P	1
Beshaw, C; Casas, O; Couderc, JP; Niu, X; Pallas-Areny, R; Rosero, S; Serrano-Finetti, E; Zareba, W	1
Abraham, J; Al-Kindi, SG; Aziz, PF; Balaji, S; Bradley, DJ; El-Assaad, I; Halsey, C; Law, IH; Sanatani, S; Shetty, I	1
Abildgaard, L; Diness, JG; Grunnet, M; Jespersen, T; Kirchhoff, JE; Sheykhzade, M	1
Shah, Y; Steinberg, JS; Szepietowska, B	1
Afzal, MR; Atkins, D; Christensen, K; Dendi, R; Di Biase, L; Hurwitz, J; Jeffrey, C; Lakkireddy, D; Lavu, M; Natale, A; Pillarisetti, J; Pimentel, R; Reddy, M; Turagam, MK; Vacek, J	1
Aziz, E; Aziz, J; Bastawrose, J; Hassan Virk, HU; Makkar, N; Qureshi, WT; Souvaliotis, N	1
Banach, M; Cattaneo, P; Mariscalco, G; Sala, A	1
Banchs, JE; Gonzalez, MD; Naccarelli, GV; Patel, PP; Penny-Peterson, ED; Samii, SM; Wolbrette, DL; Young, SK	1
Verma, A	1
Chawla, D; Coleman, CI; Ghatak, A; Kluger, J; Sood, N; Talati, R	1
Battleman, DS; Kim, MH; Klingman, D; Lin, J; Pathak, P	1
Anderson, CC; Balaji, S; Harris, L; Khairy, P; Wells, R	1
Beardsall, M; Frost, L; Khaykin, Y; Oosthuizen, R; Sarak, B; Seabrook, C; Shamiss, Y; Tsang, B; Tunney, D; Verma, A; Wulffhart, Z	1
Garikipati, NV; Kamath, GS; Khan, A; Marrero, D; Mittal, S; Steinberg, JS	1
Abildstrøm, SZ; Køber, L; Pedersen, OD; Schmiegelow, MD; Seibæk, M; Torp-Pedersen, C	1
Denetclaw, TH; Dowling, TC; Oshima, N	1
Bavikati, V; Langberg, J; Lloyd, MS; Manocha, P	1
Saklani, P; Skanes, A	1
Cleland, JG; Deedwania, PC; Khand, AU	1
Singh, BN	2
Benson, LM; Powless, D	1
Nattel, S; Schram, G; Shinagawa, K; Shiroshita-Takeshita, A	1
Bhatta, L; Hynes, J; Khan, M; Luck, J; Naccarelli, GV; Samii, S; Wolbrette, DL	1
Kao, W; Kowey, PR; Winkel, E; Yan, GX	1
Brendorp, B; Elming, H; Køber, L; Pedersen, OD; Torp-Petersen, C	1
Kramer, JM; LaPointe, NM; Pamer, CA	1
Bleich, M; Brendel, J; Busch, AE; Frenzel, J; Knobloch, K; Maier, T; Paehler, T; Rosenstein, B; Wirth, KJ	1
Khan, IA	2
Brendorp, B; Elming, H; Køber, L; Pedersen, OD; Pehrson, S; Torp-Pedersen, C	1
Singh, SN	1
Singh, S	1
Mounsey, JP; VerNooy, RA	1
Prystowsky, EN	1
Branyas, NA; Fogel, RI; Freeland, S; Padanilam, BJ; Prystowsky, EN; Rardon, DP; Rippy, JS	1
Freeland, S; Worthy, C; Zolnierz, M	1
Corley, SD; DiMarco, JP; Domanski, MJ; Epstein, AE; Geller, N; Greene, HL; Josephson, RA; Kellen, JC; Klein, RC; Krahn, AD; Mickel, M; Mitchell, LB; Nelson, JD; Rosenberg, Y; Schron, E; Shemanski, L; Waldo, AL; Wyse, DG	1
Chandra, P; Danilo, P; Kim, HY; Lee, K; Rosen, MR; Rosen, TS; Yeom, ZH	1
Pürerfellner, H	1
Borchard, R; Brandts, B; Dirkmann, D; Meine, M; Prull, MW; Trappe, HJ; Van Bracht, M; Wickenbrock, I	1
Allessie, MA; Blaauw, Y; Gögelein, H; Schotten, U; Tieleman, RG; van Hunnik, A	1
Bhatia, GS; Lip, GY	1
Reiffel, JA	2
Kantharia, BK; Ledley, GS; Nagra, BS	1
Gould, M; Thompson, C; Tsiperfal, A	1
Akhtar, M; Narayan, G; Sra, J	1
Roukoz, H; Saliba, W	1
Leung, TK; Nattel, S; Rivard, L; Schram, G; Shiroshita-Takeshita, A; Sinno, H	1
Bernard, M; Bril, A; Chalvidan, T; Cozma, D; Cozzone, P; Deharo, JC; Djiane, P; Gout, B; Kalifa, J; Laurent, P; Maixent, JM	1
Allessie, MA; Blaauw, Y; Neuberger, HR; Schotten, U; van Hunnik, A	1
Bauman, JL; Kehoe, RF; Leal, S; Mykytsey, A; Razminia, M; Saleem, M; Wang, T; Zheutlin, T	1
Kolb, C; Ndrepepa, G; Zrenner, B	1
Akiyama, T; Aktas, MK; Shah, AH	1
Brendorp, B; Burchardt, H; Elming, H; Køber, L; Pedersen, HS; Seibaek, M; Torp-Pedersen, C	1
London, B	1
Arshad, A; Aziz, E; Cotiga, D; Joshi, S; Koneru, JN; Steinberg, JS	1
Hashimoto, N; Tsuruzoe, N; Yamashita, T	1
Burke, P; Khawaja, O; Machado, C; Sekulic, M; Serafimovski, N	1
Cobbe, SM; Lip, G; Rae, AP; Sedgwick, ML	1
Crijns, HJ; Gosselink, AT; Kingma, JH; Lie, K	1
Crijns, HJ; Dalrymple, HW; De Langen, CD; Gosselink, AT; Kingma, JH; Lie, K	1
Falk, RH; Friedrich, T; Pollak, A; Singh, SN	1
Christiansen, EH; Christiansen, N; Frost, L; Mortensen, PE; Platou, ES; Tingleff, J	1
Atarashi, H; Hayakawa, H; Ino, T; Kobayashi, Y; Kuruma, A; Nomura, A; Saitoh, H	1
Liu, L; Nattel, S; St-Georges, D	1
Christensen, PD; Christiansen, EH; Graff, O; Johansen, JB; Madsen, B; Nørgaard, BL; Simonsen, EH; Wachtell, K	1
Choy, AM; Darbar, D; Dell'Orto, S; Roden, DM	1
Agner, E; Bloch-Thomsen, PE; Camm, AJ; Carlsen, J; Egstrup, K; Køber, L; Marchant, B; Møller, M; Sandøe, E; Torp-Pedersen, C; Videbaek, J	1
Stevenson, LW; Stevenson, WG	1
Markham, A; McClellan, KJ	1
Rubin, SA	1
Boden, WE; Ferraro, P; Khawari, A	1
Crijns, HJ; Dunselman, PH; Kingma, JH; Lindeboom, JE	1
Latini, R	1
Grines, CL	1
Bénardeau, A; Li, D; Nattel, S	1
Camm, AJ; Kober, L; Moller, M; Torp-Pedersen, C	1
Alboni, P; Bianconi, L; Castro, A; Dinelli, M; Pappalardo, A; Richiardi, E; Santini, M	1
DeCara, JM; Dubrey, S; Falk, RH; Pollak, A	1
Le Jemtel, TH	1
Decara, JM; Falk, RH	1
Brendorp, B; Køber, L; Torp-Pedersen, C	1
Berk, M; Billing, CB; Brodsky, MA; Feld, GK; Singh, S; Yellen, L; Zoble, RG	1
DiMarco, JP; Mounsey, JP	1
Agner, E; Bloch-Thomsen, PE; Carlsen, JE; Egstrup, K; Køber, L; Møller, M; Sandøe, E; Torp-Pedersen, CT; Videbaek, J	1
Song, JC; White, CM	1
Agner, E; Bloch Thomsen, PE; Camm, AJ; Carlsen, J; Egstrup, K; Køber, L; Marchant, B; Møller, M; Sandøe, E; Torp-Pedersen, C; Videbaek, J	1
Knobloch, K; Wirth, KJ	1
Lauer, MR	1
Derakhchan, K; Nattel, S; Talajic, M; Villemaire, C	1
Vergara, G	1
Saliba, WI	1
Boyden, PA	1
Bagger, H; Keller, N; Køber, L; Marchant, B; Pedersen, OD; Torp-Pedersen, C	1
Clifton, GD; Diaz, AL	1
Klein, GJ; Krahn, AD; Yee, R	1
Conway, DS; Lip, GY	1
Crijns, HJ; Van Gelder, IC; Van Noord, T	1
Milad, A; Racine, E; Tran, A; Vichiendilokkul, A	1
Cox, CD; Tsikouris, JP	1
Bianconi, L; Castro, A; Santini, M	1
Dunselman, PH; Kingma, JH; Polak, PE; Rasmussen, HS; Suttorp, MJ; van 't Hof, A	1

Reviews

26 review(s) available for uk 68798 and Atrial Fibrillation

Article	Year
Dofetilide for suppression of atrial fibrillation in hypertrophic cardiomyopathy: A case series and literature review. Pacing and clinical electrophysiology : PACE, 2018, Volume: 41, Issue:4 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiomyopathy, Hypertrophic; Female; Humans; Male; Middle Aged; Phenethylamines; Retrospective Studies; Sulfonamides; Treatment Outcome	2018
A Quarter of a Century Later: What is Dofetilide's Clinical Role Today? Journal of cardiovascular pharmacology and therapeutics, 2019, Volume: 24, Issue:1 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Clinical Decision-Making; Heart Conduction System; Heart Rate; Humans; Patient Selection; Phenethylamines; Potassium Channel Blockers; Risk Factors; Sulfonamides; Treatment Outcome	2019
Novel anti-arrhythmic medications in the treatment of atrial fibrillation. Current cardiology reviews, 2012, Volume: 8, Issue:4 Topics: Acetanilides; Amiodarone; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Digoxin; Dronedarone; Forecasting; Heart Failure; Humans; Phenethylamines; Piperazines; Pyrrolidines; Ranolazine; Sulfonamides; Technology, Pharmaceutical; Ventricular Dysfunction, Left	2012
Prevention of and medical therapy for atrial arrhythmias in heart failure. Heart failure reviews, 2002, Volume: 7, Issue:3 Topics: Adrenergic beta-Antagonists; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Carbazoles; Carvedilol; Drug Therapy, Combination; Electric Countershock; Heart Failure; Humans; Pacemaker, Artificial; Phenethylamines; Propanolamines; Software Design; Sulfonamides	2002
Significance and control of cardiac arrhythmias in patients with congestive cardiac failure. Heart failure reviews, 2002, Volume: 7, Issue:3 Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Death, Sudden, Cardiac; Defibrillators, Implantable; Drug Therapy, Combination; Heart Failure; Humans; Phenethylamines; Sulfonamides; Tachycardia, Ventricular; Ventricular Fibrillation	2002
Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials. The American journal of cardiology, 2003, Mar-20, Volume: 91, Issue:6A Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Australia; Canada; Controlled Clinical Trials as Topic; Europe; Flecainide; Heart Conduction System; Heart Failure; Humans; Multicenter Studies as Topic; Myocardial Infarction; Phenethylamines; Propafenone; Quinidine; Sotalol; Sulfonamides; Survival Analysis; Therapeutic Equivalency; Treatment Outcome; United States	2003
Pharmacologic and nonpharmacologic options to maintain sinus rhythm: guideline-based and new approaches. The American journal of cardiology, 2003, Mar-20, Volume: 91, Issue:6A Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Catheter Ablation; Flecainide; Heart Rate; Humans; Phenethylamines; Practice Guidelines as Topic; Propafenone; Quinidine; Stroke; Sulfonamides; Ventricular Dysfunction, Left	2003
Dofetilide: a new drug to control cardiac arrhythmia. Expert opinion on pharmacotherapy, 2003, Volume: 4, Issue:6 Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Clinical Trials as Topic; Humans; Phenethylamines; Practice Guidelines as Topic; Product Surveillance, Postmarketing; Sulfonamides; Tachycardia, Supraventricular	2003
Atrial stunning: basics and clinical considerations. International journal of cardiology, 2003, Volume: 92, Issue:2-3 Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Atrial Function; Atrial Function, Left; Atrial Function, Right; Catheter Ablation; Electric Countershock; Humans; Isoproterenol; Myocardial Stunning; Phenethylamines; Sotalol; Sulfonamides; Thromboembolism; Time Factors; Verapamil	2003
Trials of new antiarrhythmic drugs for maintenance of sinus rhythm in patients with atrial fibrillation. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2004, Volume: 10 Suppl 1 Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bridged Bicyclo Compounds, Heterocyclic; Clinical Trials as Topic; Cyclopropanes; Dronedarone; Humans; Hydantoins; Imidazoles; Imidazolidines; Indoles; Oxazines; Phenethylamines; Piperazines; Serotonin 5-HT4 Receptor Antagonists; Sulfonamides	2004
Antiarrhythmic drug therapy of atrial fibrillation. Cardiology clinics, 2004, Volume: 22, Issue:1 Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Disopyramide; Flecainide; Humans; Phenethylamines; Sotalol; Sulfonamides	2004
Recent developments in cardiovascular drug therapy: treatment of atrial arrhythmias with new class III drugs and beyond. Current medicinal chemistry. Cardiovascular and hematological agents, 2004, Volume: 2, Issue:1 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Electric Countershock; Electrophysiology; Humans; Hydantoins; Imidazolidines; Pacemaker, Artificial; Phenethylamines; Piperazines; Sulfonamides	2004
Atrial fibrillation post-myocardial infarction: frequency, consequences, and management. Current heart failure reports, 2004, Volume: 1, Issue:4 Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Heart Failure; Humans; Incidence; Myocardial Infarction; Phenethylamines; Potassium Channel Blockers; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Sulfonamides	2004
Dofetilide: a new class III antiarrhythmic agent. Expert review of cardiovascular therapy, 2007, Volume: 5, Issue:1 Topics: Action Potentials; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Dose-Response Relationship, Drug; Drug Interactions; Electrophysiologic Techniques, Cardiac; Heart Failure; Humans; Phenethylamines; Randomized Controlled Trials as Topic; Sulfonamides; Tachycardia, Supraventricular; Torsades de Pointes; Ventricular Function, Left	2007
Dofetilide: a review of its use in atrial fibrillation and atrial flutter. Drugs, 1999, Volume: 58, Issue:6 Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Humans; Phenethylamines; Sulfonamides	1999
Drug choices in the treatment of atrial fibrillation. The American journal of cardiology, 2000, May-25, Volume: 85, Issue:10A Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Electric Countershock; Humans; Phenethylamines; Sotalol; Sulfonamides	2000
Dofetilide for the treatment of atrial fibrillation in patients with congestive heart failure. European heart journal, 2000, Volume: 21, Issue:15 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Heart Failure; Heart Rate; Humans; Phenethylamines; Potassium Channel Blockers; Sulfonamides	2000
Dofetilide: a new pure class III antiarrhythmic agent. American heart journal, 2000, Volume: 140, Issue:5 Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Clinical Trials as Topic; Drug Administration Schedule; Electrophysiology; Food-Drug Interactions; Heart Conduction System; Humans; Phenethylamines; Potassium Channel Blockers; Sulfonamides; Tachycardia; Ventricular Dysfunction	2000
Dofetilide: a class III anti-arrhythmic drug for the treatment of atrial fibrillation. Expert opinion on investigational drugs, 2000, Volume: 9, Issue:11 Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Humans; Phenethylamines; Sulfonamides	2000
Cardiovascular drugs. Dofetilide. Circulation, 2000, Nov-21, Volume: 102, Issue:21 Topics: Action Potentials; Administration, Oral; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Controlled Clinical Trials as Topic; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiography; Electrophysiologic Techniques, Cardiac; Humans; Phenethylamines; Potassium; Potassium Channel Blockers; Potassium Channels; Reaction Time; Sulfonamides; Treatment Outcome; Ventricular Fibrillation	2000
Dofetilide (Tikosyn): a new drug to control atrial fibrillation. Cleveland Clinic journal of medicine, 2001, Volume: 68, Issue:4 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Interactions; Humans; Patient Selection; Phenethylamines; Potassium Channel Blockers; Sulfonamides	2001
Dofetilide: a new class III antiarrhythmic for the management of atrial fibrillation. Progress in cardiovascular nursing, 2001,Summer, Volume: 16, Issue:3 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Interactions; Humans; Phenethylamines; Randomized Controlled Trials as Topic; Sulfonamides	2001
New antiarrhythmic agents for atrial fibrillation. Current opinion in investigational drugs (London, England : 2000), 2001, Volume: 2, Issue:1 Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Hydantoins; Imidazoles; Imidazolidines; Lidocaine; Phenethylamines; Piperazines; Sulfonamides	2001
A review of class III antiarrhythmic agents for atrial fibrillation: maintenance of normal sinus rhythm. Pharmacotherapy, 2001, Volume: 21, Issue:12 Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Drug Interactions; Humans; Phenethylamines; Sotalol; Sulfonamides	2001
New antiarrhythmic drugs for the treatment of atrial fibrillation. Pacing and clinical electrophysiology : PACE, 2002, Volume: 25, Issue:2 Topics: Aminobenzoates; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bridged Bicyclo Compounds, Heterocyclic; Cyclopropanes; Dronedarone; Humans; Hydantoins; Imidazoles; Imidazolidines; Phenethylamines; Piperazines; Sotalol; Sulfonamides	2002
Transient atrial mechanical dysfunction (stunning) after cardioversion of atrial fibrillation and flutter. American heart journal, 2002, Volume: 144, Issue:1 Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Appendage; Atrial Fibrillation; Atrial Flutter; Catheter Ablation; Dogs; Electric Countershock; Heart Atria; Humans; Myocardial Contraction; Myocardial Stunning; Phenethylamines; Regional Blood Flow; Sotalol; Sulfonamides; Ultrasonography; Verapamil	2002

Trials

21 trial(s) available for uk 68798 and Atrial Fibrillation

Article	Year
Dofetilide is safe and effective in preventing atrial fibrillation recurrences in patients accepted for catheter ablation. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2009, Volume: 11, Issue:11 Topics: Atrial Fibrillation; Catheter Ablation; Female; Humans; Male; Middle Aged; Phenethylamines; Premedication; Secondary Prevention; Sulfonamides; Treatment Outcome	2009
Does conversion and prevention of atrial fibrillation enhance survival in patients with left ventricular dysfunction? Evidence from the Danish Investigations of Arrhythmia and Mortality ON Dofetilide/(DIAMOND) study. Cardiac electrophysiology review, 2003, Volume: 7, Issue:3 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Double-Blind Method; Humans; Multicenter Studies as Topic; Phenethylamines; Randomized Controlled Trials as Topic; Retrospective Studies; Sulfonamides; Ventricular Dysfunction, Left	2003
Clinical experience with dofetilide in the treatment of patients with atrial fibrillation. Journal of cardiovascular electrophysiology, 2003, Volume: 14, Issue:12 Suppl Topics: Aged; Atrial Fibrillation; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Phenethylamines; Practice Guidelines as Topic; Sulfonamides; Tachycardia, Ventricular; Treatment Outcome	2003
Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation, 2004, Mar-30, Volume: 109, Issue:12 Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Calcium Channel Blockers; Combined Modality Therapy; Comorbidity; Digoxin; Electric Countershock; Follow-Up Studies; Heart Rate; Humans; Models, Cardiovascular; Myocardial Contraction; Phenethylamines; Proportional Hazards Models; Retrospective Studies; Risk; Stroke; Sulfonamides; Survival Analysis; Treatment Failure; Treatment Outcome; Warfarin	2004
Observations on the safety and effectiveness of dofetilide in patients with paroxysmal atrial fibrillation and normal left ventricular function. Journal of cardiovascular pharmacology and therapeutics, 2007, Volume: 12, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Dose-Response Relationship, Drug; Drug Monitoring; Female; Flecainide; Follow-Up Studies; Humans; Inpatients; Long QT Syndrome; Male; Middle Aged; Phenethylamines; Propafenone; Recurrence; Sotalol; Sulfonamides; Tachycardia, Ventricular; Treatment Outcome; Ventricular Function, Left; Withholding Treatment	2007
Risk factors and predictors of Torsade de pointes ventricular tachycardia in patients with left ventricular systolic dysfunction receiving Dofetilide. The American journal of cardiology, 2007, Sep-01, Volume: 100, Issue:5 Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Output, Low; Cause of Death; Double-Blind Method; Electrocardiography; Female; Forecasting; Heart Arrest; Humans; Male; Middle Aged; Myocardial Infarction; Phenethylamines; Placebos; Potassium Channel Blockers; Risk Factors; Sex Factors; Sulfonamides; Time Factors; Torsades de Pointes; Ventricular Dysfunction, Left	2007
Usefulness of dofetilide for the prevention of atrial tachyarrhythmias (atrial fibrillation or flutter) after coronary artery bypass grafting. The American journal of cardiology, 2008, Jun-01, Volume: 101, Issue:11 Topics: Aged; Atrial Fibrillation; Atrial Flutter; Coronary Artery Bypass; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Humans; Incidence; Length of Stay; Male; Michigan; Phenethylamines; Postoperative Complications; Potassium Channel Blockers; Potassium Channels; Retrospective Studies; Sulfonamides; Survival Rate; Treatment Outcome	2008
Chemical cardioversion of atrial fibrillation with intravenous dofetilide. International journal of cardiology, 1995, Volume: 49, Issue:2 Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cross-Over Studies; Double-Blind Method; Electric Countershock; Electrocardiography, Ambulatory; Humans; Infusions, Intravenous; Middle Aged; Phenethylamines; Placebos; Potassium Channel Blockers; Potassium Channels; Sulfonamides; Torsades de Pointes	1995
Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators. Journal of the American College of Cardiology, 1997, Volume: 29, Issue:2 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Double-Blind Method; Hemodynamics; Humans; Phenethylamines; Sulfonamides; Treatment Outcome	1997
Efficacy and safety of dofetilide, a new class III antiarrhythmic agent, in acute termination of atrial fibrillation or flutter after coronary artery bypass surgery. Dofetilide Post-CABG Study Group. International journal of cardiology, 1997, Jan-31, Volume: 58, Issue:2 Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Confidence Intervals; Coronary Artery Bypass; Double-Blind Method; Female; Humans; Male; Middle Aged; Phenethylamines; Placebo Effect; Postoperative Complications; Sample Size; Sulfonamides; Treatment Outcome	1997
Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled trial. Danish Dofetilide in Atrial Fibrillation and Flutter Study Group. American heart journal, 1999, Volume: 137, Issue:6 Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Denmark; Double-Blind Method; Female; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Phenethylamines; Placebos; Potassium Channel Blockers; Prospective Studies; Safety; Sulfonamides; Time Factors	1999
Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. The New England journal of medicine, 1999, Sep-16, Volume: 341, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Double-Blind Method; Electrocardiography; Female; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Phenethylamines; Secondary Prevention; Sulfonamides; Survival Analysis; Torsades de Pointes; Ventricular Dysfunction, Left	1999
Efficacy and safety of intravenous dofetilide for rapid termination of atrial fibrillation and atrial flutter. The American journal of cardiology, 2000, Apr-15, Volume: 85, Issue:8 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Phenethylamines; Potassium Channel Blockers; Safety; Sulfonamides; Time Factors	2000
[Dofetilide in patients with chronic heart failure and left ventricular dysfunction]. Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology, 2000, Volume: 1, Issue:3 Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channel Blockers; Electric Countershock; Female; Follow-Up Studies; Heart Failure; Humans; Male; Phenethylamines; Potassium Channel Blockers; Risk Factors; Sulfonamides; Time Factors; Ventricular Dysfunction, Left	2000
Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. A multicentre, randomized, double-blind, placebo-controlled study. European heart journal, 2000, Volume: 21, Issue:15 Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Blood Pressure; Double-Blind Method; Electrocardiography; Female; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Phenethylamines; Potassium Channel Blockers; Prognosis; Sulfonamides; Vasodilator Agents	2000
Positive atrial inotropic effect of dofetilide after cardioversion of atrial fibrillation or flutter. The American journal of cardiology, 2000, Sep-15, Volume: 86, Issue:6 Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Blood Flow Velocity; Double-Blind Method; Echocardiography, Doppler, Color; Electric Countershock; Heart Rate; Humans; Myocardial Contraction; Phenethylamines; Potassium Channel Blockers; Recurrence; Stroke Volume; Sulfonamides	2000
Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study. Circulation, 2000, Nov-07, Volume: 102, Issue:19 Topics: Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Double-Blind Method; Drug Administration Schedule; Female; Heart Rate; Humans; Male; Middle Aged; Phenethylamines; Placebos; Sulfonamides; Treatment Outcome	2000
[Dofetilide to patients with heart failure and left ventricular dysfunction]. Ugeskrift for laeger, 2000, Oct-30, Volume: 162, Issue:44 Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cause of Death; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Phenethylamines; Sulfonamides; Ventricular Dysfunction, Left	2000
Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial. Lancet (London, England), 2000, Dec-16, Volume: 356, Issue:9247 Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Double-Blind Method; Female; Humans; Male; Middle Aged; Myocardial Infarction; Phenethylamines; Sulfonamides; Ventricular Dysfunction, Left	2000
Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy. Circulation, 2001, Jul-17, Volume: 104, Issue:3 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Chronic Disease; Denmark; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Phenethylamines; Sulfonamides; Survival Rate; Treatment Outcome; Ventricular Dysfunction, Left	2001
A randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of intravenously administered dofetilide in patients with Wolff-Parkinson-White syndrome. Pacing and clinical electrophysiology : PACE, 2001, Volume: 24, Issue:8 Pt 1 Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Double-Blind Method; Electrophysiologic Techniques, Cardiac; Humans; Infusions, Intravenous; Male; Middle Aged; Phenethylamines; Pilot Projects; Sulfonamides; Tachycardia, Atrioventricular Nodal Reentry; Wolff-Parkinson-White Syndrome	2001

Other Studies

90 other study(ies) available for uk 68798 and Atrial Fibrillation

Article	Year
Longitudinal QT Journal of cardiovascular electrophysiology, 2022, Volume: 33, Issue:6 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Humans; Long QT Syndrome; Male; Patient Discharge; Phenethylamines; Retrospective Studies; Sulfonamides	2022
MATE1 Deficiency Exacerbates Dofetilide-Induced Proarrhythmia. International journal of molecular sciences, 2022, Aug-03, Volume: 23, Issue:15 Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Mice; Phenethylamines; Sulfonamides	2022
Assessment of Sotalol and Dofetilide Dosing at a Large Academic Medical Center. Journal of cardiovascular pharmacology and therapeutics, 2020, Volume: 25, Issue:5 Topics: Academic Medical Centers; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Boston; Drug Dosage Calculations; Drug Monitoring; Female; Heart Rate; Humans; Long QT Syndrome; Male; Middle Aged; Phenethylamines; Practice Patterns, Physicians'; Retrospective Studies; Risk Assessment; Risk Factors; Sotalol; Sulfonamides; Torsades de Pointes	2020
Clinical Outcomes and Characteristics With Dofetilide in Atrial Fibrillation Patients Considered for Implantable Cardioverter-Defibrillator. Circulation. Arrhythmia and electrophysiology, 2020, Volume: 13, Issue:7 Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Databases, Factual; Defibrillators, Implantable; Electric Countershock; Female; Heart Rate; Humans; Male; Middle Aged; Phenethylamines; Recovery of Function; Recurrence; Retrospective Studies; Stroke Volume; Sulfonamides; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left	2020
Outpatient initiation of dofetilide: insights from the complexities of atrial fibrillation management during the COVID-19 lockdown. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2022, Volume: 63, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Communicable Disease Control; COVID-19; Female; Humans; Outpatients; Phenethylamines; SARS-CoV-2; Sulfonamides	2022
Safety of Inpatient Dofetilide Initiation per Cardiology Services: A Retrospective Review. Journal of pharmacy practice, 2022, Volume: 35, Issue:4 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiology; Heart Arrest; Humans; Inpatients; Phenethylamines; Retrospective Studies; Sulfonamides	2022
Comparative Efficacy of Dofetilide Versus Amiodarone in Patients With Atrial Fibrillation. JACC. Clinical electrophysiology, 2021, Volume: 7, Issue:5 Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Humans; Male; Middle Aged; Phenethylamines; Stroke Volume; Sulfonamides; Ventricular Function, Left	2021
Modeling Atrial Fibrillation using Human Embryonic Stem Cell-Derived Atrial Tissue. Scientific reports, 2017, 07-13, Volume: 7, Issue:1 Topics: Action Potentials; Atrial Fibrillation; Cells, Cultured; Heart Atria; Human Embryonic Stem Cells; Humans; Models, Biological; Phenethylamines; Potassium Channel Blockers; Sulfonamides	2017
Comparison of the effects of I Canadian journal of physiology and pharmacology, 2018, Volume: 96, Issue:1 Topics: Action Potentials; Animals; Atrial Fibrillation; Atrial Remodeling; Bee Venoms; Consciousness; Dogs; Electrocardiography; Heart Atria; Male; Phenethylamines; Potassium Channel Blockers; Potassium Channels; Propafenone; Receptors, Cholinergic; Refractory Period, Electrophysiological; Sulfonamides	2018
Antiarrhythmic Effects of Combining Dofetilide and Ranolazine in a Model of Acutely Induced Atrial Fibrillation in Horses. Journal of cardiovascular pharmacology, 2018, Volume: 71, Issue:1 Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease Models, Animal; Drug Combinations; Female; Heart Rate; Horses; Infusions, Intravenous; Male; Phenethylamines; Ranolazine; Sulfonamides	2018
Dofetilide dose reductions and discontinuations in women compared with men. Heart rhythm, 2018, Volume: 15, Issue:4 Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Electrocardiography; Female; Humans; Incidence; Male; Middle Aged; North Carolina; Phenethylamines; Retrospective Studies; Risk Factors; Sex Factors; Sulfonamides; Torsades de Pointes	2018
Whole-exome sequencing reveals microsatellite DNA markers for response to dofetilide initiation in patients with persistent atrial fibrillation: A pilot study. Clinical cardiology, 2018, Volume: 41, Issue:6 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Decision-Making; Exome Sequencing; Heart Rate; Humans; Microsatellite Repeats; Patient Selection; Pharmacogenetics; Pharmacogenomic Variants; Phenethylamines; Pilot Projects; Polymorphism, Genetic; Predictive Value of Tests; Preliminary Data; Prospective Studies; Sulfonamides; Time Factors; Treatment Outcome; Virginia	2018
Potentially modifiable factors of dofetilide-associated risk of torsades de pointes among hospitalized patients with atrial fibrillation. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2019, Volume: 54, Issue:2 Topics: Academic Medical Centers; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Case-Control Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography; Female; Heart Rate; Hospitalization; Humans; Logistic Models; Long QT Syndrome; Male; Middle Aged; Multivariate Analysis; Observer Variation; Phenethylamines; Prognosis; Retrospective Studies; Risk Assessment; Sulfonamides; Survival Rate; Torsades de Pointes; Treatment Outcome	2019
Effects of dofetilide and ranolazine on atrial fibrillatory rate in a horse model of acutely induced atrial fibrillation. Journal of cardiovascular electrophysiology, 2019, Volume: 30, Issue:4 Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease Models, Animal; Drug Therapy, Combination; Electrocardiography; Female; Heart Rate; Horses; Male; Phenethylamines; Potassium Channel Blockers; Ranolazine; Sodium Channel Blockers; Sulfonamides; Time Factors	2019
Stroke or side effect? dofetilide associated facial paralysis after direct current cardioversion for atrial fibrillation. BMJ case reports, 2019, Jan-29, Volume: 12, Issue:1 Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Diagnosis, Differential; Electric Countershock; Facial Paralysis; Humans; Male; Phenethylamines; Stroke; Sulfonamides	2019
Safety of rapid switching from amiodarone to dofetilide in atrial fibrillation patients with an implantable cardioverter-defibrillator. Heart rhythm, 2019, Volume: 16, Issue:7 Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Defibrillators, Implantable; Female; Hospitalization; Humans; Male; Middle Aged; Phenethylamines; Retrospective Studies; Sulfonamides	2019
Frequency of toxicity with chemical conversion of atrial fibrillation with dofetilide. The American journal of cardiology, 2013, Aug-15, Volume: 112, Issue:4 Topics: Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Chi-Square Distribution; Electric Countershock; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Middle Aged; Phenethylamines; Recurrence; Retrospective Studies; Sulfonamides; Torsades de Pointes	2013
Correlation of QT interval correction methods during atrial fibrillation and sinus rhythm. The American journal of cardiology, 2013, Nov-01, Volume: 112, Issue:9 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Dose-Response Relationship, Drug; Electrocardiography; Female; Follow-Up Studies; Heart Rate; Humans; Male; Middle Aged; Phenethylamines; Prognosis; Retrospective Studies; Sulfonamides	2013
Usefulness of pharmacologic conversion of atrial fibrillation during dofetilide loading without the need for electrical cardioversion to predict durable response to therapy. The American journal of cardiology, 2014, Feb-01, Volume: 113, Issue:3 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Electrocardiography; Female; Follow-Up Studies; Heart Rate; Humans; Male; Middle Aged; Phenethylamines; Recurrence; Retrospective Studies; Sulfonamides; Treatment Outcome	2014
Combination use of ranolazine with dofetilide for the maintenance of atrial fibrillation. International journal of cardiology, 2014, Apr-01, Volume: 172, Issue:3 Topics: Acetanilides; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Enzyme Inhibitors; Follow-Up Studies; Humans; Male; Phenethylamines; Piperazines; Ranolazine; Sodium Channel Blockers; Sulfonamides	2014
Three heart medications in short supply in Canada. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2014, Mar-18, Volume: 186, Issue:5 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Canada; Flecainide; Humans; Phenethylamines; Propafenone; Sulfonamides	2014
Considerations for dofetilide use in the elderly. The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2014, Volume: 29, Issue:4 Topics: Aged, 80 and over; Anti-Arrhythmia Agents; Antihypertensive Agents; Atrial Fibrillation; Chlorthalidone; Drug Interactions; Female; Humans; Hypertension; Hypotension; Phenethylamines; Sulfonamides	2014
Electrocardiographic markers of repolarization heterogeneity during dofetilide or sotalol initiation for paroxysmal atrial fibrillation. The American journal of cardiology, 2014, Jun-15, Volume: 113, Issue:12 Topics: Age Factors; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cohort Studies; Diagnosis, Computer-Assisted; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography; Female; Heart Rate; Humans; Logistic Models; Male; Middle Aged; Phenethylamines; Recovery of Function; Retrospective Studies; Risk Assessment; Sex Factors; Software; Sotalol; Sulfonamides; Tachycardia, Paroxysmal; Treatment Outcome	2014
Effects of the selective KACh channel blocker NTC-801 on atrial fibrillation in a canine model of atrial tachypacing: comparison with class Ic and III drugs. Journal of cardiovascular pharmacology, 2014, Volume: 63, Issue:5 Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Dogs; Electrocardiography; Flecainide; Heart Atria; Heart Conduction System; Phenethylamines; Potassium Channel Blockers; Receptors, Cholinergic; Sulfonamides; Tachycardia	2014
Acute conversion of persistent atrial fibrillation during dofetilide loading does not predict long-term atrial fibrillation-free survival. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2015, Volume: 42, Issue:2 Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Chronic Disease; Cohort Studies; Disease-Free Survival; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Phenethylamines; Predictive Value of Tests; Proportional Hazards Models; Pulse Therapy, Drug; Recurrence; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sulfonamides; Time Factors; Treatment Outcome	2015
Risk prediction for adverse events during initiation of sotalol and dofetilide for the treatment of atrial fibrillation. Pacing and clinical electrophysiology : PACE, 2015, Volume: 38, Issue:4 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Comorbidity; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Illinois; Long QT Syndrome; Male; Middle Aged; Phenethylamines; Prevalence; Retrospective Studies; Risk Factors; Sotalol; Sulfonamides; Treatment Outcome; Ventricular Fibrillation	2015
Surface ECG f Wave Analysis of Dofetilide Drug Effect in the Atrium. Journal of cardiovascular electrophysiology, 2015, Volume: 26, Issue:6 Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Female; Fourier Analysis; Heart Atria; Humans; Male; Middle Aged; Phenethylamines; Retrospective Studies; Sulfonamides	2015
Safety of oral dofetilide for rhythm control of atrial fibrillation and atrial flutter. Circulation. Arrhythmia and electrophysiology, 2015, Volume: 8, Issue:4 Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cause of Death; Dose-Response Relationship, Drug; Electrocardiography; Female; Follow-Up Studies; Heart Rate; Humans; Male; Ohio; Phenethylamines; Retrospective Studies; Sulfonamides; Treatment Outcome	2015
Comparative effectiveness of antiarrhythmic drugs for rhythm control of atrial fibrillation. Journal of cardiology, 2016, Volume: 67, Issue:5 Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cohort Studies; Dronedarone; Female; Humans; Male; Patient Admission; Pennsylvania; Phenethylamines; Recurrence; Retrospective Studies; Sotalol; Stroke; Sulfonamides	2016
Magnitude of increase in QTc interval after initiation of dofetilide in patients with persistent atrial fibrillation is associated with increased rates of pharmacological cardioversion and long-term freedom from recurrent atrial fibrillation. Heart rhythm, 2016, Volume: 13, Issue:7 Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cohort Studies; Electric Countershock; Electrocardiography; Female; Heart Conduction System; Humans; Male; Massachusetts; Middle Aged; Phenethylamines; Recurrence; Retrospective Studies; Sulfonamides	2016
The QT Scale: A Weight Scale Measuring the QTc Interval. Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2017, Volume: 22, Issue:1 Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Female; Heart Conduction System; Heart Rate; Humans; Long QT Syndrome; Male; Middle Aged; Phenethylamines; Sulfonamides	2017
Use of dofetilide in adult patients with atrial arrhythmias and congenital heart disease: A PACES collaborative study. Heart rhythm, 2016, Volume: 13, Issue:10 Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Monitoring; Electrocardiography; Female; Heart Defects, Congenital; Hospitalization; Humans; Male; Middle Aged; Outcome and Process Assessment, Health Care; Phenethylamines; Retrospective Studies; Sulfonamides; Tachycardia, Atrioventricular Nodal Reentry; United States; Withholding Treatment	2016
Antiarrhythmic effect of the Ca Pflugers Archiv : European journal of physiology, 2016, Volume: 468, Issue:11-12 Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Synergism; Guinea Pigs; Heart; Heart Rate; Isolated Heart Preparation; Phenethylamines; Potassium Channel Blockers; Pyridines; Small-Conductance Calcium-Activated Potassium Channels; Sulfonamides; Thiazoles	2016
Pharmacologic Conversion during Dofetilide Treatment for Persistent Atrial Fibrillation. Pacing and clinical electrophysiology : PACE, 2017, Volume: 40, Issue:6 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Causality; Chronic Disease; Cohort Studies; Comorbidity; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Middle Aged; New York; Phenethylamines; Retrospective Studies; Risk Factors; Sulfonamides; Torsades de Pointes; Treatment Outcome	2017
Practice variation in the re-initiation of dofetilide: An observational study. International journal of cardiology, 2017, Jun-01, Volume: 236 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiologists; Humans; Phenethylamines; Practice Guidelines as Topic; Sulfonamides; Surveys and Questionnaires; Treatment Outcome	2017
Short- and long-term clinical predictors of pharmacological cardioversion of persistent atrial fibrillation by dofetilide: A retrospective cohort study of 160 patients. Clinical cardiology, 2017, Volume: 40, Issue:7 Topics: Atrial Fibrillation; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heart Rate; Humans; Male; Middle Aged; Patient Readmission; Phenethylamines; Potassium Channel Blockers; Retrospective Studies; Sulfonamides; Time Factors; Treatment Outcome	2017
Dofetilide for the prevention of postoperative atrial fibrillation after coronary surgery: is it a useful routine prophylaxis? The American journal of cardiology, 2008, Aug-15, Volume: 102, Issue:4 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypass; Humans; Incidence; Phenethylamines; Risk Factors; Risk Reduction Behavior; Sulfonamides	2008
Efficacy and safety of dofetilide in patients with atrial fibrillation and atrial flutter. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2008, Volume: 23, Issue:2 Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Chi-Square Distribution; Electrocardiography; Female; Humans; Male; Middle Aged; Phenethylamines; Sulfonamides; Treatment Outcome	2008
Alternatives to amiodarone: search for the Holy Grail. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2009, Volume: 11, Issue:4 Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Benzofurans; Combined Modality Therapy; Dose-Response Relationship, Drug; Dronedarone; Humans; Pacemaker, Artificial; Phenethylamines; Sulfonamides	2009
Intravenous magnesium sulfate enhances the ability of dofetilide to successfully cardiovert atrial fibrillation or flutter: results of the Dofetilide and Intravenous Magnesium Evaluation. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2009, Volume: 11, Issue:7 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Calcium Channel Blockers; Cohort Studies; Drug Synergism; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Magnesium Sulfate; Male; Middle Aged; Phenethylamines; Retrospective Studies; Sulfonamides; Treatment Outcome	2009
Cost of hospital admission for antiarrhythmic drug initiation in atrial fibrillation. The Annals of pharmacotherapy, 2009, Volume: 43, Issue:5 Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Health Care Costs; Hospitalization; Humans; Male; Middle Aged; Phenethylamines; Retrospective Studies; Sotalol; Sulfonamides	2009
Dofetilide for atrial arrhythmias in congenital heart disease: a multicenter study. Pacing and clinical electrophysiology : PACE, 2009, Volume: 32, Issue:10 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Canada; Female; Heart Defects, Congenital; Humans; Male; Phenethylamines; Retrospective Studies; Sulfonamides; Treatment Outcome; United States	2009
Pulmonary vein isolation alone in patients with persistent atrial fibrillation: an ablation strategy facilitated by antiarrhythmic drug induced reverse remodeling. Journal of cardiovascular electrophysiology, 2011, Volume: 22, Issue:2 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Chronic Disease; Combined Modality Therapy; Female; Heart Conduction System; Humans; Male; Middle Aged; Phenethylamines; Pulmonary Veins; Sulfonamides; Treatment Outcome	2011
Incidence of atrial fibrillation in patients with either heart failure or acute myocardial infarction and left ventricular dysfunction: a cohort study. BMC cardiovascular disorders, 2011, May-14, Volume: 11 Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Chi-Square Distribution; Cohort Studies; Denmark; Electrocardiography; Female; Heart Failure; Humans; Incidence; Kaplan-Meier Estimate; Male; Multicenter Studies as Topic; Myocardial Infarction; Phenethylamines; Proportional Hazards Models; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Stroke Volume; Sulfonamides; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left	2011
Dofetilide dose calculation errors in elderly associated with use of the modification of diet in renal disease equation. The Annals of pharmacotherapy, 2011, Volume: 45, Issue:7-8 Topics: Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy; Creatinine; Drug Dosage Calculations; Electric Countershock; Female; Glomerular Filtration Rate; Humans; Male; Medication Errors; Phenethylamines; Renal Insufficiency, Chronic; Severity of Illness Index; Sulfonamides	2011
Coronary artery disease potentiates response to dofetilide for rhythm control of atrial fibrillation. Pacing and clinical electrophysiology : PACE, 2012, Volume: 35, Issue:2 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Comorbidity; Coronary Artery Disease; Drug Synergism; Female; Georgia; Humans; Male; Middle Aged; Phenethylamines; Prevalence; Sulfonamides; Treatment Outcome	2012
Dofetilide and atrial fibrillation. The American journal of nursing, 2003, Volume: 103, Issue:2 Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Female; Humans; Middle Aged; Phenethylamines; Prevalence; Sulfonamides; United States	2003
Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium: insights into the mechanism of the superior efficacy of amiodarone. Circulation, 2003, Mar-18, Volume: 107, Issue:10 Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channels, L-Type; Dogs; Electrocardiography; Electrophysiology; Flecainide; Heart Atria; Phenethylamines; Refractory Period, Electrophysiological; Sulfonamides; Tachycardia	2003
New antiarrhythmic agents for atrial fibrillation and atrial flutter: United States drug market response as an indicator of acceptance. Pharmacotherapy, 2003, Volume: 23, Issue:10 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Databases, Factual; Drug Prescriptions; Drug Utilization; Humans; Phenethylamines; Sotalol; Sulfonamides; United States	2003
Atrial effects of the novel K(+)-channel-blocker AVE0118 in anesthetized pigs. Cardiovascular research, 2003, Nov-01, Volume: 60, Issue:2 Topics: Action Potentials; Animals; Atrial Fibrillation; Cardiac Pacing, Artificial; Heart Atria; Kv1.5 Potassium Channel; Male; Myocardial Contraction; Myocardium; Phenethylamines; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Shal Potassium Channels; Sulfonamides; Swine	2003
Role of dofetilide in patients with atrial fibrillation. Insights from the Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) study. Cardiac electrophysiology review, 2003, Volume: 7, Issue:3 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Dose-Response Relationship, Drug; Electrocardiography; Humans; Phenethylamines; Potassium Channel Blockers; Sulfonamides	2003
Introduction--roundtable on atrial fibrillation: update on mechanisms and approaches to treatment. Journal of cardiovascular electrophysiology, 2003, Volume: 14, Issue:12 Suppl Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Catheter Ablation; Humans; Palliative Care; Phenethylamines; Sulfonamides; Treatment Outcome	2003
Initiation and monitoring of class III antiarrhythmic agents. Journal of cardiovascular electrophysiology, 2003, Volume: 14, Issue:12 Suppl Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Administration Schedule; Drug Approval; Drug Labeling; Drug Monitoring; Drug Therapy, Computer-Assisted; Humans; Patient Care Management; Patient Care Team; Phenethylamines; Practice Guidelines as Topic; Sotalol; Sulfonamides; Torsades de Pointes	2003
Evaluation of KCB-328, a new IKr blocking antiarrhythmic agent in pacing induced canine atrial fibrillation. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2004, Volume: 6, Issue:5 Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Female; Heart Atria; Heart Ventricles; Phenethylamines; Potassium Channel Blockers; Propafenone; Random Allocation; Sodium Channel Blockers; Sulfonamides	2004
[Perspectives and limitations in the treatment of vagus-induced atrial fibrillation. Insights from cellular pharmacology]. Medizinische Klinik (Munich, Germany : 1983), 2004, Jul-15, Volume: 99, Issue:7 Topics: Adult; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Cells, Cultured; Culture Media; Heart Atria; Humans; Membrane Potentials; Phenethylamines; Potassium Channel Blockers; Rats; Sotalol; Sulfonamides; Time Factors; Vagus Nerve	2004
"Early" class III drugs for the treatment of atrial fibrillation: efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat. Circulation, 2004, Sep-28, Volume: 110, Issue:13 Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Delayed Rectifier Potassium Channels; Drug Evaluation, Preclinical; Electric Countershock; Female; Goats; Heart Atria; Heart Conduction System; Infusions, Intravenous; Ion Transport; Neural Conduction; Phenethylamines; Potassium; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Sulfonamides	2004
Atypical proarrhythmia with dofetilide: monomorphic VT and exercise-induced torsade de pointes. Pacing and clinical electrophysiology : PACE, 2005, Volume: 28, Issue:8 Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Exercise Test; Humans; Male; Middle Aged; Phenethylamines; Sulfonamides; Tachycardia, Ventricular; Torsades de Pointes; Ventricular Premature Complexes	2005
Marked QT prolongation and torsades de pointes secondary to acute ischemia in an elderly man taking dofetilide for atrial fibrillation: a cautionary tale. Journal of cardiovascular pharmacology and therapeutics, 2005, Volume: 10, Issue:3 Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Humans; Male; Myocardial Ischemia; Phenethylamines; Sulfonamides; Torsades de Pointes	2005
What is drug-induced long QT and what is a potential clinical consequence? Progress in cardiovascular nursing, 2006,Spring, Volume: 21, Issue:2 Topics: Action Potentials; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Monitoring; Electrocardiography; Humans; Long QT Syndrome; Male; Metabolic Clearance Rate; Nursing Assessment; Phenethylamines; Sulfonamides; Telemetry; Torsades de Pointes	2006
Combined use of 1C and III agents for highly symptomatic, refractory atrial fibrillation. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2006, Volume: 15, Issue:3 Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Chronic Disease; Drug Combinations; Female; Flecainide; Humans; Male; Middle Aged; Phenethylamines; Propafenone; Secondary Prevention; Sotalol; Sulfonamides; Treatment Failure; Treatment Outcome	2006
The pharmacological response of ischemia-related atrial fibrillation in dogs: evidence for substrate-specific efficacy. Cardiovascular research, 2007, Apr-01, Volume: 74, Issue:1 Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channel Blockers; Coronary Disease; Diltiazem; Dogs; Electric Stimulation; Flecainide; Models, Animal; Nadolol; Phenethylamines; Potassium Channel Blockers; Refractory Period, Electrophysiological; Sodium Channel Blockers; Sulfonamides; Vagus Nerve	2007
Anti-arrhythmic effects of I (Na), I (Kr), and combined I (Kr)-I (CaL) blockade in an experimental model of acute stretch-related atrial fibrillation. Cardiovascular drugs and therapy, 2007, Volume: 21, Issue:1 Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Function; Benzamides; Dose-Response Relationship, Drug; Electrophysiologic Techniques, Cardiac; Female; Flecainide; In Vitro Techniques; Male; Myocardial Contraction; Perfusion; Phenethylamines; Potassium Channels, Calcium-Activated; Potassium Channels, Inwardly Rectifying; Rabbits; Sodium Channel Blockers; Stress, Mechanical; Sulfonamides; Time Factors	2007
Cardioversion of persistent atrial fibrillation by a combination of atrial specific and non-specific class III drugs in the goat. Cardiovascular research, 2007, Jul-01, Volume: 75, Issue:1 Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Biphenyl Compounds; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electric Countershock; Electrocardiography; Female; Goats; Phenethylamines; Sulfonamides	2007
Late dofetilide-associated life-threatening proarrhythmia. International journal of cardiology, 2008, Jul-04, Volume: 127, Issue:2 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Defibrillators, Implantable; Electrocardiography; Humans; Male; Middle Aged; Phenethylamines; Sulfonamides; Tachycardia, Ventricular; Ventricular Fibrillation	2008
Dofetilide-induced long QT and torsades de pointes. Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2007, Volume: 12, Issue:3 Topics: Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Middle Aged; Phenethylamines; Risk Factors; Sulfonamides; Torsades de Pointes	2007
Amiodarone and atrial fibrillation. Journal of cardiovascular electrophysiology, 2007, Volume: 18, Issue:12 Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Function; Biphenyl Compounds; Dose-Response Relationship, Drug; Female; Goats; Heart Conduction System; Injections, Intravenous; Male; Phenethylamines; Potassium Channel Blockers; Sulfonamides; Swine	2007
Acute conversion of persistent atrial fibrillation during dofetilide initiation. Pacing and clinical electrophysiology : PACE, 2007, Volume: 30, Issue:12 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Dose-Response Relationship, Drug; Female; Humans; Logistic Models; Male; Middle Aged; Phenethylamines; Sulfonamides; Treatment Outcome	2007
Characterization of in vivo and in vitro electrophysiological and antiarrhythmic effects of a novel IKACh blocker, NIP-151: a comparison with an IKr-blocker dofetilide. Journal of cardiovascular pharmacology, 2008, Volume: 51, Issue:2 Topics: Aconitine; Action Potentials; Analysis of Variance; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Benzopyrans; Cell Line; Dogs; Dose-Response Relationship, Drug; Electrocardiography; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Female; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Hemodynamics; Humans; Inhibitory Concentration 50; Male; Patch-Clamp Techniques; Phenethylamines; Potassium Channel Blockers; Rabbits; Refractory Period, Electrophysiological; Sulfonamides; Vagus Nerve; Ventricular Function, Right	2008
Comparison in the same patient of aberrant conduction and bundle branch reentry after dofetilide, a new selective class III antiarrhythmic agent. Pacing and clinical electrophysiology : PACE, 1993, Volume: 16, Issue:5 Pt 1 Topics: Action Potentials; Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Bundle of His; Cardiac Pacing, Artificial; Electrocardiography; Heart Conduction System; Humans; Male; Phenethylamines; Refractory Period, Electrophysiological; Sulfonamides	1993
Sequential bilateral bundle branch block during dofetilide, a new class III antiarrhythmic agent, in a patient with atrial fibrillation. Journal of cardiovascular electrophysiology, 1993, Volume: 4, Issue:4 Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Bundle-Branch Block; Electrocardiography; Heart Conduction System; Humans; Male; Phenethylamines; Sulfonamides	1993
Acute conversion of atrial fibrillation and flutter: direct current cardioversion versus intravenously administered pure class III agents. Journal of the American College of Cardiology, 1997, Volume: 29, Issue:2 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electric Countershock; Humans; Phenethylamines; Sulfonamides; Treatment Outcome	1997
Clinical and electrophysiologic effects of dofetilide in patients with supraventricular tachyarrhythmias. Journal of cardiovascular pharmacology, 1997, Volume: 30, Issue:3 Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrophysiology; Female; Heart; Humans; Injections, Intravenous; Male; Middle Aged; Phenethylamines; Sulfonamides; Tachycardia, Supraventricular	1997
Effects of the novel antiarrhythmic agent azimilide on experimental atrial fibrillation and atrial electrophysiologic properties. Cardiovascular research, 1998, Volume: 37, Issue:3 Topics: Analysis of Variance; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Chi-Square Distribution; Dogs; Drug Administration Schedule; Electrocardiography; Female; Heart Atria; Heart Rate; Hydantoins; Imidazoles; Imidazolidines; Male; Phenethylamines; Piperazines; Potassium Channel Blockers; Sulfonamides	1998
Exaggerated QT prolongation after cardioversion of atrial fibrillation. Journal of the American College of Cardiology, 1999, Volume: 34, Issue:2 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electric Countershock; Electrocardiography; Female; Heart Rate; Humans; Male; Phenethylamines; Sulfonamides	1999
Atrial fibrillation in heart failure. The New England journal of medicine, 1999, Sep-16, Volume: 341, Issue:12 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Heart Failure; Humans; Phenethylamines; Sulfonamides	1999
Dofetilide for atrial fibrillation. The New England journal of medicine, 2000, Jan-27, Volume: 342, Issue:4 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Heart Failure; Hospitalization; Humans; Phenethylamines; Sulfonamides; Torsades de Pointes	2000
Dofetilide for atrial fibrillation. The New England journal of medicine, 2000, Jan-27, Volume: 342, Issue:4 Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atrial Fibrillation; Digoxin; Drug Interactions; Drug Therapy, Combination; Heart Failure; Humans; Phenethylamines; Sulfonamides	2000
Safety and effectiveness of dofetilide for conversion of atrial fibrillation and nesiritide for acute decompensation of heart failure: a report from the cardiovascular and renal advisory panel of the Food and Drug Administration. Circulation, 2000, May-30, Volume: 101, Issue:21 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Natriuretic Factor; Cardiovascular Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Phenethylamines; Potassium Channel Blockers; Sulfonamides; Therapeutic Equivalency	2000
Dofetilide for atrial fibrillation. The Medical letter on drugs and therapeutics, 2000, May-15, Volume: 42, Issue:1078 Topics: Anti-Arrhythmia Agents; Anti-Infective Agents; Anti-Infective Agents, Urinary; Anti-Ulcer Agents; Antifungal Agents; Atrial Fibrillation; Cimetidine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Interactions; Humans; Ketoconazole; Phenethylamines; Potassium Channel Blockers; Sulfamethoxazole; Sulfonamides; Torsades de Pointes; Trimethoprim	2000
Contrasting efficacy of dofetilide in differing experimental models of atrial fibrillation. Circulation, 2000, Jul-04, Volume: 102, Issue:1 Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Blood Pressure; Disease Models, Animal; Dogs; Electrocardiography; Heart Failure; Heart Ventricles; Pacemaker, Artificial; Pericardium; Phenethylamines; Sulfonamides; Ventricular Remodeling	2000
Management of heart failure. Current cardiology reports, 2000, Volume: 2, Issue:3 Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Disease; Heart Failure; Humans; Myocardial Revascularization; Phenethylamines; Ramipril; Randomized Controlled Trials as Topic; Sulfonamides; Ventricular Dysfunction, Left	2000
Dofetilide (Tikosyn). Connecticut medicine, 2000, Volume: 64, Issue:10 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Phenethylamines; Sulfonamides	2000
Differential effects of dofetilide, amiodarone, and class lc drugs on left and right atrial refractoriness and left atrial vulnerability in pigs. Naunyn-Schmiedeberg's archives of pharmacology, 2001, Volume: 363, Issue:2 Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Atrial Function, Left; Atrial Function, Right; Flecainide; Male; Phenethylamines; Propafenone; Sulfonamides; Swine	2001
Dofetilide: is the treatment worse than the disease? Journal of the American College of Cardiology, 2001, Mar-15, Volume: 37, Issue:4 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Clinical Trials as Topic; Humans; Phenethylamines; Sulfonamides; Tachycardia, Ventricular	2001
The class III antiarrhythmic drugs dofetilide and sotalol prevent AF induction by atrial premature complexes at doses that fail to terminate AF. Cardiovascular research, 2001, Volume: 50, Issue:1 Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Premature Complexes; Dogs; Drug Administration Schedule; Electric Stimulation; Electrophysiology; Heart Conduction System; Phenethylamines; Refractory Period, Electrophysiological; Sotalol; Sulfonamides	2001
[Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter]. Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology, 2001, Volume: 2, Issue:3 Topics: Administration, Oral; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Chronic Disease; Clinical Trials as Topic; Humans; Phenethylamines; Sulfonamides	2001
Three things you should know when considering the atria: location, location, location. Circulation research, 2001, Jun-08, Volume: 88, Issue:11 Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Cation Transport Proteins; Chronic Disease; Disease Progression; DNA-Binding Proteins; Dogs; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Heart Atria; Heart Conduction System; Mice; Phenethylamines; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Rats; Sulfonamides; Trans-Activators	2001
Pericardioversion dofetilide does not suppress immediate and subacute recurrences of persistent atrial fibrillation. Circulation, 2001, Sep-11, Volume: 104, Issue:11 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Phenethylamines; Recurrence; Sulfonamides; Treatment Outcome	2001
Practical approach to the use and monitoring of dofetilide therapy. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2001, Nov-01, Volume: 58, Issue:21 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Drug Monitoring; Humans; Phenethylamines; Sulfonamides	2001
Efficacy and safety of a new selective class III antiarrhythmic agent dofetilide in paroxysmal atrial fibrillation or atrial flutter. The American journal of cardiology, 1992, Feb-01, Volume: 69, Issue:4 Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Blood Pressure; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Male; Middle Aged; Phenethylamines; Sulfonamides; Tachycardia, Paroxysmal	1992